Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Study directly links gut leakage with retinopathy severity in people with Type 1 diabetes

The leading cause of blindness in American adults is diabetic retinopathy, progressive damage to blood vessels in the light-sensitive tissue at the back of the eye.

14 Jan 2023

A need for more research on how lifestyle interventions could help high-risk pregnant populations

The prevalence of chronic hypertension (CH) and type 1 diabetes mellitus (DM) or type 2 diabetes mellitus (T2DM) has increased considerably in the pregnant population over the recent decades. Notably, the percentage of its occurrence has continued to rise due to increasing rates of obesity and advances in maternal age. Obesity is a key risk factor influencing CH or DM/T2DM.

5 Jan 2023

A gloomy outlook for type 1 diabetes in children and adolescents by 2050

A study published in The Lancet Diabetes and Endocrinology journal estimates the global incidence of type 1 diabetes in children and adolescents using microsimulation models.

5 Jan 2023

What are the long-term consequences following COVID-19 and other viral respiratory infections?

Researchers compared coronavirus disease 2019 (COVID-19)-specific long-term consequences to other viral respiratory infections.

29 Dec 2022

Wafer-thin device could drastically alter the course of treatment for Type 1 diabetes

A quarter-sized device created at Houston Methodist could drastically alter the course of treatment for Type 1 diabetes, a chronic condition that impacts millions of Americans and does not have a cure.

27 Dec 2022

Cellular models based on reprogrammed human cells could boost development of efficient therapies

Studies on diseases that affect the human brain are usually based on animal models which cannot reproduce the complexity of human neuropathies.

22 Dec 2022

Exposure to blue-green algae toxin shown to wreak havoc on gut bacteria and cause liver damage

Exposure to a specific type of blue-green algae toxin known as cylindrospermopsin has shown to wreak havoc on gut bacteria and an increased probability of irritable bowel syndrome, inflammatory bowel disease, celiac disease, type 1 diabetes, obesity and inflammation of the liver – a precursor to liver cancer – according to a study led by the University of California, Irvine.

20 Dec 2022

Revised guidelines for diabetes care

A recent Diabetes Care journal paper summarized the latest recommendations offered to people with diabetes to improve their health and well-being.

15 Dec 2022

Study provides new insights for the future development of oral insulin pill

WEHI researchers in Melbourne have answered a 100-year-old question in diabetes research: can a molecule different to insulin have the same effect? The findings provide important insights for the future development of an oral insulin pill.

12 Dec 2022

Study of 1.1 million children finds no association between SARS-CoV-2 infection and type 1 diabetes risk

Researchers investigate whether the risk of new-onset type 1 diabetes is elevated by SARS-CoV-2 infections among children living in Denmark.

11 Dec 2022

Antibodies against gentamicin associated with increased risk of type 1 diabetes in children

Antibodies produced against the commonly used antibiotic, gentamicin, appear to increase the risk of type 1 diabetes in children already genetically at risk, scientists say.

8 Dec 2022

New Clinical Practice Guideline offers recommendations to manage hypoglycemia in people with diabetes

People with diabetes are benefiting from advances in medications and technologies to lower their risk of hypoglycemia, according to a Clinical Practice Guideline issued today by the Endocrine Society.

7 Dec 2022

Parkinson’s drug improves blood pressure, aortic stiffness in adolescents with Type 1 diabetes

Teens with Type 1 diabetes (T1D) who took bromocriptine, a medication used to treat Parkinson's disease and Type 2 diabetes, had lower blood pressure and less stiff arteries after one month of treatment compared to those who did not take the medicine, according to a small study published today in Hypertension, an American Heart Association journal.

6 Dec 2022

Research project obtains nearly seven million to study factors that affect human immune system in early life

The first few months and years of life are crucial to the development of the human immune system. This is an important phase as the immune system can define which diseases individuals might develop later in life.

2 Dec 2022

Discovery could lead to new mantle cell lymphoma drugs

A form of blood cancer known as mantle cell lymphoma is critically dependent on a protein that coordinates gene expression, such that blocking its activity with an experimental drug dramatically slows the growth of this lymphoma in preclinical tests, according to a study from Weill Cornell Medicine researchers.

22 Nov 2022

Elevated incidence and risk for a new diagnosis of diabetes after COVID-19

In a recent study published in the journal BMC Medicine, researchers estimated the prevalence of new-onset diabetes following coronavirus disease 2019 (COVID-19).

21 Nov 2022

FDA approves first-ever type 1 diabetes delaying drug Tzield (teplizumab-mzwv)

On November 17, 2022, the US Food and Drug Administration (FDA) approved a pathbreaking new drug called Tzield. This injectable formulation contains a combination of two drugs that could push back the onset of type 1 diabetes (T1D) in adults at stage 3 and children aged eight years or more at stage 2.

20 Nov 2022

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Study directly links gut leakage with retinopathy severity in people with Type 1 diabetes

A need for more research on how lifestyle interventions could help high-risk pregnant populations

A gloomy outlook for type 1 diabetes in children and adolescents by 2050

What are the long-term consequences following COVID-19 and other viral respiratory infections?

Wafer-thin device could drastically alter the course of treatment for Type 1 diabetes

Cellular models based on reprogrammed human cells could boost development of efficient therapies

Exposure to blue-green algae toxin shown to wreak havoc on gut bacteria and cause liver damage

Revised guidelines for diabetes care

Study provides new insights for the future development of oral insulin pill

Study of 1.1 million children finds no association between SARS-CoV-2 infection and type 1 diabetes risk

Antibodies against gentamicin associated with increased risk of type 1 diabetes in children

New Clinical Practice Guideline offers recommendations to manage hypoglycemia in people with diabetes

Parkinson’s drug improves blood pressure, aortic stiffness in adolescents with Type 1 diabetes

Research project obtains nearly seven million to study factors that affect human immune system in early life

Discovery could lead to new mantle cell lymphoma drugs

Elevated incidence and risk for a new diagnosis of diabetes after COVID-19

FDA approves first-ever type 1 diabetes delaying drug Tzield (teplizumab-mzwv)

World Diabetes Day 2022: The Importance of Type 1 Research and Awareness with JDRF

TYK2 inhibitor identifies as a promising drug candidate for preventing type 1 diabetes

The direct and indirect effects of COVID-19 on people with type 1 and type 2 diabetes

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in